Opioid Dependence Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Key Companies - Sen Jam Pharmaceutical, AstraZeneca, Lyndra Therapeutics, Indivior Inc., Jazz

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Opioid Dependence pipeline constitutes 35+ key companies continuously working towards developing 40+ Opioid Dependence treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Opioid Dependence Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Opioid Dependence Market.

The Opioid Dependence Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Opioid Dependence Pipeline Report: https://www.delveinsight.com/report-store/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Opioid Dependence treatment therapies with a considerable amount of success over the years.
• Opioid Dependence companies working in the treatment market are Gilgamesh Pharmaceuticals, oresee Pharmaceuticals, Sen Jam Pharmaceutical, AstraZeneca, Lyndra Therapeutics, Indivior Inc., Jazz Pharmaceuticals, Orexo AB, and others, are developing therapies for the Opioid Dependence treatment
• Emerging Opioid Dependence therapies such as - GM-300X, FP 004, SJP 006, AZD4041, LYN-014, INDV-2000, Cannabidi0l, OX 124, and others are expected to have a significant impact on the Opioid Dependence market in the coming years.
• In July 2020, Indivior Inc. initiated a trial titled, "A Phase I, Double-blind, Placebo-controlled, Randomized, Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of INDV-2000 (C4X_3256) Under Fasting and Fed Conditions in Healthy Volunteers"
• In August 2022, a phase I double-blind, placebo-controlled experiment named "A Phase I Double-Blind, Placebo-Controlled Randomised Study to Assess Repeated Doses of INDV-2000 (C4X_3256) up to 28 Days in Healthy Volunteers, and an Open-Label Study ofINDV-2000 up to 11 Days in Treatment Seeking Individuals With Opioid Use Disorder" was started by Indivior Inc.
• In December 2022, the resubmitted New Drug Application (NDA) for Brixadi (buprenorphine) extended-release weekly and monthly subcutaneous injection was approved by the US Food and Drug Administration (FDA) for the treatment of moderate to severe opioid use disorder in patients who started treatment with a single dose of a transmucosal buprenorphine product or who are already receiving buprenorphine treatment.

Opioid Dependence Overview
Opioid dependence is a chronic relapsing medical disorder afflicting millions worldwide, including as many as two million people in the United States. Untreated and ineffectively treated opioid dependence contributes to premature mortality and costly emergent use of health care and social services. O

Get a Free Sample PDF Report to know more about Opioid Dependence Pipeline Therapeutic Assessment-
https://www.delveinsight.com/sample-request/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Opioid Dependence Drugs Under Different Phases of Clinical Development Include:
• GM-300X: Gilgamesh Pharmaceuticals
• FP 004: oresee Pharmaceuticals
• APH-1501: Aphios
• DMX-1002: DemeRx IB, Inc.
• Noribogaine: DemeRx IB, Inc.
• SJP 006: Sen Jam Pharmaceutical
• AZD4041: AstraZeneca
• LYN-014: Lyndra Therapeutics
• INDV-2000: Indivior Inc.
• Cannabidi0l: Jazz Pharmaceuticals
• OX 124: Orexo AB

Route of Administration
Opioid Dependence pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Intravenous
• Subcutaneous
• Parenteral
• Topical

Molecule Type
Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Opioid Dependence Pipeline Therapeutics Assessment
• Opioid Dependence Assessment by Product Type
• Opioid Dependence By Stage and Product Type
• Opioid Dependence Assessment by Route of Administration
• Opioid Dependence By Stage and Route of Administration
• Opioid Dependence Assessment by Molecule Type
• Opioid Dependence by Stage and Molecule Type

DelveInsight's Opioid Dependence Report covers around 40+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Opioid Dependence product details are provided in the report. Download the Opioid Dependence pipeline report to learn more about the emerging Opioid Dependence therapies at:
https://www.delveinsight.com/sample-request/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Opioid Dependence Therapeutics Market include:
Key companies developing therapies for Opioid Dependence are - Sen Jam Pharmaceutical, Mindmed, Emergent BioSolutions, Opiant Pharmaceuticals, ATAI Life Sciences, Aphios, Inventage Lab Inc., Trevena Inc., Foresee Pharmaceuticals Co., Ltd, DemeRx, AphioTx Inc., Lyndra Therapeutics, AstraZeneca, Orexo AB, Alar Pharmaceuticals, Ensysce biosciences, Gilgamesh Pharmaceuticals, Indivior, Cerevel Therapeutics, BioCorRx, Kinoxis Therapeutics, Aptinyx, and others.

Opioid Dependence Pipeline Analysis:
The Opioid Dependence pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Opioid Dependence with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Opioid Dependence Treatment.
• Opioid Dependence key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Opioid Dependence Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Opioid Dependence market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Opioid Dependence drugs and therapies-
https://www.delveinsight.com/sample-request/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Opioid Dependence Pipeline Market Drivers
• Rising number of incidences of Opioid Abuse, increased R&D Activities are some of the important factors that are fueling the Opioid Dependence Market.

Opioid Dependence Pipeline Market Barriers
• However, side effects associated with the treatment, lack of sufficient number of Opioid treatment programs and other factors are creating obstacles in the Opioid Dependence Market growth.

Scope of Opioid Dependence Pipeline Drug Insight
• Coverage: Global
• Key Opioid Dependence Companies: Gilgamesh Pharmaceuticals, oresee Pharmaceuticals, Sen Jam Pharmaceutical, AstraZeneca, Lyndra Therapeutics, Indivior Inc., Jazz Pharmaceuticals, Orexo AB, and others
• Key Opioid Dependence Therapies: GM-300X, FP 004, SJP 006, AZD4041, LYN-014, INDV-2000, Cannabidi0l, OX 124, and others
• Opioid Dependence Therapeutic Assessment: Opioid Dependence current marketed and Opioid Dependence emerging therapies
• Opioid Dependence Market Dynamics: Opioid Dependence market drivers and Opioid Dependence market barriers

Request for Sample PDF Report for Opioid Dependence Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Opioid Dependence Report Introduction
2 Opioid Dependence Executive Summary
3 Opioid Dependence Overview
4 Opioid Dependence- Analytical Perspective In-depth Commercial Assessment
5 Opioid Dependence Pipeline Therapeutics
6 Opioid Dependence Late Stage Products (Phase II/III)
7 Opioid Dependence Mid Stage Products (Phase II)
8 Opioid Dependence Early Stage Products (Phase I)
9 Opioid Dependence Preclinical Stage Products
10 Opioid Dependence Therapeutics Assessment
11 Opioid Dependence Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Opioid Dependence Key Companies
14 Opioid Dependence Key Products
15 Opioid Dependence Unmet Needs
16 Opioid Dependence Market Drivers and Barriers
17 Opioid Dependence Future Perspectives and Conclusion
18 Opioid Dependence Analyst Views
19 Appendix
20 About DelveInsight
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Related Reports:

Opioid Dependence Market
https://www.delveinsight.com/report-store/opioid-dependence-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Opioid Dependence-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Opioid Dependence Epidemiology
https://www.delveinsight.com/report-store/opioid-dependence-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Opioid Dependence Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
Scedosporium Infection Market https://www.delveinsight.com/report-store/scedosporium-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Scedosporium Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Scedosporium Infection, historical and forecasted epidemiology as well as the Scedosporium Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Vascular Graft Devices Market https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2027 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Vascular Stents Market https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2027 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Bladder Scanners Market https://www.delveinsight.com/report-store/bladder-scanners-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Recent Blog's By DelveInsight:

• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Contact Us:

Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
www.delveinsight.com/consulting

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.